168 related articles for article (PubMed ID: 35705529)
1. Disabled, invisible and dismissed-The lived experience of fatigue in people with myeloproliferative neoplasms.
Bradford A; Young K; Whitechurch A; Burbury K; Pearson EJM
Cancer Rep (Hoboken); 2023 Jan; 6(1):e1655. PubMed ID: 35705529
[TBL] [Abstract][Full Text] [Related]
2. Tobacco use in the Myeloproliferative neoplasms: symptom burden, patient opinions, and care.
Christensen SF; Scherber RM; Mazza GL; Dueck AC; Brochmann N; Andersen CL; Hasselbalch HC; Mesa RA; Geyer HL
BMC Cancer; 2021 Jun; 21(1):691. PubMed ID: 34112113
[TBL] [Abstract][Full Text] [Related]
3. Perceptions of Myeloproliferative Neoplasm Patients Participating in an Online Yoga Intervention: A Qualitative Study.
Huberty J; Eckert R; Larkey L; Gowin K; Mitchell J; Mesa R
Integr Cancer Ther; 2018 Dec; 17(4):1150-1162. PubMed ID: 30352518
[TBL] [Abstract][Full Text] [Related]
4. Daily living and rehabilitation needs in patients and caregivers affected by myeloproliferative neoplasms (MPN): A qualitative study.
Rossau HK; Kjerholt M; Brochmann N; Tang LH; Dieperink KB
J Clin Nurs; 2022 Apr; 31(7-8):909-921. PubMed ID: 34231273
[TBL] [Abstract][Full Text] [Related]
5. The SIMM study: Survey of integrative medicine in myeloproliferative neoplasms.
Gowin K; Langlais BT; Kosiorek HE; Dueck A; Millstine D; Huberty J; Eckert R; Mesa RA
Cancer Med; 2020 Dec; 9(24):9445-9453. PubMed ID: 33140580
[TBL] [Abstract][Full Text] [Related]
6. Depressive symptoms and myeloproliferative neoplasms: Understanding the confounding factor in a complex condition.
Padrnos L; Scherber R; Geyer H; Langlais BT; Dueck AC; Kosiorek HE; Senyak Z; Clark M; Boxer M; Cotter M; Harrison C; Stonnington C; Geda Y; Mesa R
Cancer Med; 2020 Nov; 9(22):8301-8309. PubMed ID: 32976697
[TBL] [Abstract][Full Text] [Related]
7. Approach to MPN Symptom Assessment.
Geyer H; Mesa RA
Curr Hematol Malig Rep; 2017 Oct; 12(5):381-388. PubMed ID: 28942516
[TBL] [Abstract][Full Text] [Related]
8. Myeloproliferative neoplasms (MPNs) have a significant impact on patients' overall health and productivity: the MPN Landmark survey.
Mesa R; Miller CB; Thyne M; Mangan J; Goldberger S; Fazal S; Ma X; Wilson W; Paranagama DC; Dubinski DG; Boyle J; Mascarenhas JO
BMC Cancer; 2016 Feb; 16():167. PubMed ID: 26922064
[TBL] [Abstract][Full Text] [Related]
9. The role of sexuality symptoms in myeloproliferative neoplasm symptom burden and quality of life: An analysis by the MPN QOL International Study Group.
Geyer HL; Andreasson B; Kosiorek HE; Dueck AC; Scherber RM; Martin KA; Butler KA; Harrison CN; Radia DH; Cervantes F; Kiladjian JJ; Reiter A; Birgegard G; Passamonti F; Senyak Z; Vannucchi AM; Paoli C; Xiao Z; Samuelsson J; Mesa RA
Cancer; 2016 Jun; 122(12):1888-96. PubMed ID: 27070130
[TBL] [Abstract][Full Text] [Related]
10. The impact of myeloproliferative neoplasms (MPNs) on patient quality of life and productivity: results from the international MPN Landmark survey.
Harrison CN; Koschmieder S; Foltz L; Guglielmelli P; Flindt T; Koehler M; Mathias J; Komatsu N; Boothroyd RN; Spierer A; Perez Ronco J; Taylor-Stokes G; Waller J; Mesa RA
Ann Hematol; 2017 Oct; 96(10):1653-1665. PubMed ID: 28780729
[TBL] [Abstract][Full Text] [Related]
11. Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.
Busolo D; Woodgate R
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):99-111. PubMed ID: 26447011
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of the MPN Landmark survey for impact and perceptions of treatment goals among Chinese physicians and myeloproliferative neoplasm patients].
Xu ZF; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2020 Jul; 41(7):570-575. PubMed ID: 32810964
[No Abstract] [Full Text] [Related]
13. How myeloproliferative neoplasms patients' experience and expectations differ from physicians': the international MPN Landmark survey.
Byun JM; Bang SM; Choi EJ; Eom KS; Jung CW; Kim HS; Park J; Choi CW
Korean J Intern Med; 2022 Mar; 37(2):444-454. PubMed ID: 35272443
[TBL] [Abstract][Full Text] [Related]
14. Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs.
Emanuel RM; Dueck AC; Geyer HL; Kiladjian JJ; Slot S; Zweegman S; te Boekhorst PA; Commandeur S; Schouten HC; Sackmann F; Kerguelen Fuentes A; Hernández-Maraver D; Pahl HL; Griesshammer M; Stegelmann F; Doehner K; Lehmann T; Bonatz K; Reiter A; Boyer F; Etienne G; Ianotto JC; Ranta D; Roy L; Cahn JY; Harrison CN; Radia D; Muxi P; Maldonado N; Besses C; Cervantes F; Johansson PL; Barbui T; Barosi G; Vannucchi AM; Passamonti F; Andreasson B; Ferrari ML; Rambaldi A; Samuelsson J; Birgegard G; Tefferi A; Mesa RA
J Clin Oncol; 2012 Nov; 30(33):4098-103. PubMed ID: 23071245
[TBL] [Abstract][Full Text] [Related]
15. The personal impact of living with a myeloproliferative neoplasm.
Eppingbroek AAM; Lechner L; Bakker EC; Nijkamp MD; de Witte MA; Bolman CAW
Psychooncology; 2024 Apr; 33(4):e6338. PubMed ID: 38610117
[TBL] [Abstract][Full Text] [Related]
16. Living with an MPN in Ireland: patients' and caregivers' perspectives.
Walpole G; Kelly M; Lewis J; Gleeson A; Cullen AM; Wochal P
Br J Nurs; 2021 Sep; 30(17):S24-S30. PubMed ID: 34605263
[TBL] [Abstract][Full Text] [Related]
17. Quality of life in MPN comes of age as a therapeutic target.
Scherber RM; Geyer HL; Mesa RA
Curr Hematol Malig Rep; 2014 Dec; 9(4):324-30. PubMed ID: 25262210
[TBL] [Abstract][Full Text] [Related]
18. UK results from the myeloproliferative neoplasms (MPN) landmark survey on the symptom, emotional and economic burden of MPN.
Harrison C; Mathias J; Campbell-Drew M; Mead AJ; Pemberton-Whiteley Z; Ali S; Wadelin F; Taylor-Stokes G; Waller J; Taylor B
Br J Haematol; 2019 Aug; 186(3):e1-e4. PubMed ID: 30854625
[No Abstract] [Full Text] [Related]
19. Relationship between symptom burden and disability leave among patients with myeloproliferative neoplasms (MPNs): findings from the Living with MPN patient survey.
Yu J; Paranagama D; Geyer HL; Parasuraman S; Mesa R
Ann Hematol; 2019 May; 98(5):1119-1125. PubMed ID: 30694363
[TBL] [Abstract][Full Text] [Related]
20. Patients with polycythemia vera have worst impairment of quality of life among patients with newly diagnosed myeloproliferative neoplasms.
Abelsson J; Andréasson B; Samuelsson J; Hultcrantz M; Ejerblad E; Johansson B; Emanuel R; Mesa R; Johansson P
Leuk Lymphoma; 2013 Oct; 54(10):2226-30. PubMed ID: 23398206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
